Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
about
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.Cancer immunotherapy: When viruses attack.Immunotherapy: When viruses attack.Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.CNS cancer immunity cycle and strategies to target this for glioblastoma.Recurrent Glioblastoma Treated with Recombinant Poliovirus.A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumorsEngineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer CellsRecombinant poliovirus for cancer immunotherapyActivation of viral defense signaling in cancerTreatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
P2860
Q47100447-125908E3-BC76-4B41-A96C-25F1DEB4C7C9Q47596792-266A0A62-9247-4085-9938-4CA6CA54CE28Q47614845-380D73E9-AAA7-4F7F-A328-D4119F952159Q54965295-03DF49CD-167C-4891-A4A6-B11BE47EB3D4Q55259532-4538936F-01B5-41FC-B441-E83023BAD67EQ55456747-DF27E923-4F3F-47D9-97CF-6ED614BB02FDQ56348401-312BA5ED-5685-4CEB-BDC7-248271B15118Q57753028-50E2A749-F842-4733-879B-D90426E8BF0CQ58127679-AF157F16-75C4-4989-BD24-02ECFF61C9C2Q58695217-E9CB23BD-D677-46FA-8368-AFDA56F1AA23Q58708239-C1537A96-C1FB-43EF-9329-A830DBC234F5
P2860
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cancer immunotherapy with reco ...... d tumor antigen-specific CTLs.
@en
Cancer immunotherapy with reco ...... d tumor antigen-specific CTLs.
@nl
type
label
Cancer immunotherapy with reco ...... d tumor antigen-specific CTLs.
@en
Cancer immunotherapy with reco ...... d tumor antigen-specific CTLs.
@nl
prefLabel
Cancer immunotherapy with reco ...... d tumor antigen-specific CTLs.
@en
Cancer immunotherapy with reco ...... d tumor antigen-specific CTLs.
@nl
P2860
P50
P1476
Cancer immunotherapy with reco ...... nd tumor antigen-specific CTLs
@en
P2093
David Boczkowski
P2860
P356
10.1126/SCITRANSLMED.AAN4220
P407
P50
P577
2017-09-01T00:00:00Z